News Psyence Group Inc.

Equities

PSYG

CA74449Q1063

Delayed Canadian Securities Exchange Other stock markets 01:17:22 2024-05-15 pm EDT			5-day change	1st Jan Change
0.02 ^CAD	-20.00%		-20.00%	-60.00%

Mar. 26	Psyence Group Closes Strategic Restructuring of Its Non-Clinical Business	MT
Mar. 26	An undisclosed buyer completed the acquisition of Mind Health Ltd and Psyence Uk Group Ltd from Psyence Group Inc..	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Psyence : NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial	May. 06	PU
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial	Apr. 16	GL
Psyence Group Closes Strategic Restructuring of Its Non-Clinical Business	Mar. 26	MT
Psyence Group Announces the Closing of the Previously Announced Strategic Restructuring of Its Non-Clinical Business	Mar. 26	AQ
An undisclosed buyer completed the acquisition of Mind Health Ltd and Psyence Uk Group Ltd from Psyence Group Inc..	Mar. 25	CI
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study	Mar. 12	GL
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study	Mar. 12	AQ
Psyence Group Provides Corporate Update Following Successful Spac Spin Out of Therapeutic Division	Mar. 11	MT
Psyence Group Provides Corporate Update Following Successful Spac Spin Out of Therapeutic Division	Mar. 11	GL
Psyence Group Provides Corporate Update Following Successful Spac Spin Out of Therapeutic Division	Mar. 11	AQ
Psyence Group Inc. Announces Resignation of Neil Maresky as CEO	Mar. 11	CI
Psyence Group Inc. Announces CFO Changes	Mar. 11	CI
Psyence Group Inc. Announces Board Resignations	Mar. 11	CI
An undisclosed buyer entered into a conditional agreement to acquire Mind Health Ltd and Psyence Uk Group Ltd from Psyence Group Inc. for CAD 1 million.	Mar. 10	CI
Psyence Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 28	CI
Psyence Biomedical Approved to List on Nasdaq Following Completion of Business Combination With Newcourt Acquisition Corp	Jan. 26	MT
Psyence Biomedical Ltd. Approved to List on Nasdaq following Completion of Business Combination Agreement with Newcourt Acquisition Corp	Jan. 25	GL
Psyence Biomedical Ltd. Approved to List on Nasdaq following Completion of Business Combination Agreement with Newcourt Acquisition Corp	Jan. 25	AQ
Psyence Group Inc Subsidiary Psyence Biomedical Ltd. announces signing of definitive agreement for a convertible note in connection with planned business combination	Jan. 16	GL
Psyence Group Inc. Announces Resignation of Marvin Singer as Board Member	Nov. 20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Psyence Group Inc.

Equities

PSYG

CA74449Q1063

Summary

Filters